BRAINSTORM CELL THERAPEUTICS INC. Quarterly Return On Equity in % from Q4 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2011 to Q3 2024.
  • Brainstorm Cell Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was 285 %, a 38.7% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2023 was 425 %.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2022 was -469 %, a 430% decline from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Return On Equity for 2021 was -88.4 %, a 44.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 285 -180 -38.7% Jul 1, 2024 Sep 30, 2024
Q2 2024 309 -552 -64.1% Apr 1, 2024 Jun 30, 2024
Q1 2024 368 +7.3K Jan 1, 2024 Mar 31, 2024
Q4 2023 425 +894 Oct 1, 2023 Dec 31, 2023
Q3 2023 465 +701 Jul 1, 2023 Sep 30, 2023
Q2 2023 861 +1K Apr 1, 2023 Jun 30, 2023
Q1 2023 -6.93K -6.83K -6553% Jan 1, 2023 Mar 31, 2023
Q4 2022 -469 -380 -430% Oct 1, 2022 Dec 31, 2022
Q3 2022 -236 -141 -149% Jul 1, 2022 Sep 30, 2022
Q2 2022 -144 -52.2 -57.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -104 +8.85 +7.83% Jan 1, 2022 Mar 31, 2022
Q4 2021 -88.4 +70.1 +44.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -94.9 +245 +72.1% Jul 1, 2021 Sep 30, 2021
Q2 2021 -91.5 -69.2K -100% Apr 1, 2021 Jun 30, 2021
Q1 2021 -113 -839 -116% Jan 1, 2021 Mar 31, 2021
Q4 2020 -159 -560 -140% Oct 1, 2020 Dec 31, 2020
Q3 2020 -340 -1.75K -124% Jul 1, 2020 Sep 30, 2020
Q2 2020 69.1K +69.7K Apr 1, 2020 Jun 30, 2020
Q1 2020 726 +963 Jan 1, 2020 Mar 31, 2020
Q4 2019 401 +577 Oct 1, 2019 Dec 31, 2019
Q3 2019 1.41K +1.51K Jul 1, 2019 Sep 30, 2019
Q2 2019 -684 -576 -532% Apr 1, 2019 Jun 30, 2019
Q1 2019 -237 -138 -140% Jan 1, 2019 Mar 31, 2019
Q4 2018 -176 -102 -136% Oct 1, 2018 Dec 31, 2018
Q3 2018 -102 -25.4 -33.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 -108 -52 -92.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -98.5 -49.4 -101% Jan 1, 2018 Mar 31, 2018
Q4 2017 -74.4 -30 -67.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -76.4 -29.6 -63.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -56.2 -6.39 -12.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -49.1 +4.46 +8.33% Jan 1, 2017 Mar 31, 2017
Q4 2016 -44.4 +6.15 +12.2% Oct 1, 2016 Dec 31, 2016
Q3 2016 -46.8 +19.1 +29% Jul 1, 2016 Sep 30, 2016
Q2 2016 -49.8 +22.9 +31.5% Apr 1, 2016 Jun 30, 2016
Q1 2016 -53.6 +28.2 +34.5% Jan 1, 2016 Mar 31, 2016
Q4 2015 -50.6 +86.2 +63% Oct 1, 2015 Dec 31, 2015
Q3 2015 -65.9 +68 +50.8% Jul 1, 2015 Sep 30, 2015
Q2 2015 -72.7 +63.8 +46.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -81.8 +144 +63.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -137 +12.7 +8.48% Oct 1, 2014 Dec 31, 2014
Q3 2014 -134 -15.2 -12.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -137 -15.3 -12.6% Apr 1, 2014 Jun 30, 2014
Q1 2014 -226 -106 -89% Jan 1, 2014 Mar 31, 2014
Q4 2013 -149 -5.22 -3.62% Oct 1, 2013 Dec 31, 2013
Q3 2013 -119 +250 +67.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 -121 +370 +75.3% Apr 1, 2013 Jun 30, 2013
Q1 2013 -120 +118 +49.6% Jan 1, 2013 Mar 31, 2013
Q4 2012 -144 +35.1 +19.6% Oct 1, 2012 Dec 31, 2012
Q3 2012 -369 Jul 1, 2012 Sep 30, 2012
Q2 2012 -491 Apr 1, 2012 Jun 30, 2012
Q1 2012 -237 Jan 1, 2012 Mar 31, 2012
Q4 2011 -179 Oct 1, 2011 Dec 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.